The majority of patients with chronic kidney disease are anaemic. Iron deficiency should be
corrected before treatment with recombinant human erythropoietin (rhuEpo) or novel …

Iron deficiency is a frequent complication in patients with chronic kidney disease (CKD).
Major causes are reduced dietary intake, impaired absorption, chronic blood loss …

Absolute and functional iron deficiency is the most common cause of epoetin (recombinant
human erythropoietin) hyporesponsiveness in renal failure patients. Diagnostic procedures …

We have been invited to write this article, exploring While there are several factors that
contribute to the question of whether we expose our patients to suboptimal haematocrit …

An adequate supply of bioavailable iron is crucial for an optimal response to recombinant
human erythropoietin (EPO)[1, 2]. However, the amount of iron needed as the necessary …

Beneficial effects of iron therapy in renal failure patients on hemodialysis. Iron deficiency is a
common problem in patients treated with hemodialysis. If not detected and treated …

Background. Correction of anaemia as a result of renal failure improves cardiovascular
function and also provides significant cognitive and emotional benefits. The most …

During the past decade, the integration of recombinant human erythropoietin (EPO) and
maintenance intravenous iron therapy into standard anemia management protocols has …

Much progress has been made in recent years in the management of anemia associated
with chronic and renal failure with recombinant human erythropoietin (r-Hu EPO). However …

Iron overload in renal failure patients: Changes since the introduction of erythropoietin
therapy. Iron overload was a common complication in patients with chronic renal failure …